Article
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
American journal of human genetics - 5 Dec 2019
Kay Chris, Collins Jennifer A, Caron Nicholas S, Agostinho Luciana de Andrade, Findlay-Black Hailey, Casal Lorenzo, Sumathipala Dulika, Dissanayake Vajira H W, Cornejo-Olivas Mario, Baine Fiona, Krause Amanda, Greenberg Jacquie L, Paiva Carmen Lúcia Antão, Squitieri Ferdinando, Hayden Michael R
Abstract excerpt
Huntington disease (HD) is a fatal neurodegenerative disorder caused by a gain-of-function mutation in HTT. Suppression of mutant HTT has emerged as a leading therapeutic strategy for HD, with allele-selective approaches targeting HTT SNPs now in clinical trials. Haplotypes associated with the HD mutation (A1, A2, A3a) represent panels of allele-specific gene silencing targets for efficient treatment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
